Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy - Wikidata - awgldk - TriplyDB

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy

http://www.wikidata.org/entity/Q34658087

about

New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia Mediterranean diet and health: food effects on gut microbiota and disease control Gut/brain axis and the microbiota Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver Alcoholic liver disease: the gut microbiome and liver cross talk Intestinal permeability in a patient with liver cirrhosis Implication of the intestinal microbiome in complications of cirrhosis Gut microbiota: its role in hepatic encephalopathy Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy Gut microbes and the brain: paradigm shift in neuroscience.Gut microbiome perturbations induced by bacterial infection affect arsenic biotransformation Antibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed Macaques Gut Microbiota and Complications of Liver Disease.Hepatic encephalopathy in acute-on-chronic liver failure.Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy.The role of microbiota in hepatic encephalopathy Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis.Gut microbiota-related complications in cirrhosis Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship.The gut microbiota and the liver: implications for clinical practice.Altered profile of human gut microbiome is associated with cirrhosis and its complications.Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286.Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis.Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis.Rifaximin: a review of its use in reducing recurrence of overt hepatic encephalopathy episodes.Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study.Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature.Obesity, Asthma, and the Microbiome.Antibiotics as deep modulators of gut microbiota: between good and evil.Alzheimer's disease and gut microbiota.

P2860

Q26748617-44211EC0-2CAA-49AF-9B02-B8FF11620982 Q26775927-28B9FF3B-BAA2-4BBF-80F6-7885FBBB97C4 Q26778000-227E4E01-F77F-4133-A04B-DFE7D2777968 Q26826919-C8C416FF-CA99-40DA-B1B5-A18C8D464340 Q26829951-CC441FF0-892B-4A8C-8665-A7D25E487FF2 Q26998106-E2DEB0B2-93F1-477E-A8DB-32F8FC88B986 Q27001540-8BFCDED0-E4F3-47A4-BE69-47EE221E1349 Q27025627-11F55293-569F-4185-B80A-47AC30145D01 Q28067113-B34D5D9A-462B-47E0-8909-FF8F9418B807 Q28068832-15B5FBF1-ED0E-4C58-A106-37A214666167 Q28084576-0E22D7E5-7BCB-4BD6-BB01-8034C248F647 Q28236913-F4E6A4D2-58B3-43E9-95C7-FA77DF0FF3DC Q28251501-7C13C2D4-8557-470A-9C15-41CD3D73640C Q28383247-39296F7E-2B93-49F8-9A18-8D0D87A2E3C5 Q28552448-B130A3F6-A456-42C7-A3B8-617A8AF57DC8 Q30236024-76D2A1CD-E4DA-432A-91B7-DF30AB703A5A Q30959584-A4051139-B64B-4EF5-A62F-CC3570FE19A2 Q33465655-2FF1AA94-C0D2-4111-B2A9-8EA69506A33E Q34129402-42881188-D62C-4159-A764-394808A4F503 Q34135613-38BE5E2F-A714-4783-B13E-EA209696A346 Q34499061-51711961-53D9-4DDA-B5F5-33AE06CB64D3 Q34647371-BFDBBA03-996F-42E4-A86D-F678B78CF60C Q34817375-AB047DFA-B1DB-4869-AA94-294D081C060E Q35019661-A559F18F-1ED7-477B-9102-08FA85618E3A Q35077209-80970FD2-A6E2-4A9E-BF86-5E9129700566 Q35102590-C763BBFE-B8D2-4F9B-8C85-61B47FACF2EE Q35120488-055F3826-E840-4374-9279-AB29307622B1 Q35143004-6FD1EB36-6320-4BC3-A555-663DBFFE020C Q35170336-06C5491B-78B2-49E4-87DB-4EB04CAC9984 Q35373588-5253964D-A849-46F3-831C-F4AE6E3623F3 Q35589590-34CFDDBC-2728-47BA-B330-23A342F3591A Q35653362-0B95EBA4-DB35-4E79-BD87-4D741E79CD9A Q35810550-D75C6132-9149-4C0E-BDFC-0F5507FCED1A Q35855740-343422F0-2847-438B-B62B-872F68BCD1BB Q35870133-51351529-04B7-4A64-B128-865DAB023C2A Q35875078-C672BA90-4A8B-4514-B750-F5133C529BDF Q35906455-6CE029DA-1729-4217-AE63-DBC2491A3BAE Q35926923-758D8576-0CF3-4A45-89F2-F5F63617DE6B Q36105508-9EBEC419-5ED9-4F44-85D6-48227964B357 Q36114884-5EE786C4-B3F0-4B4D-8B6B-8D93F820166B

P2860

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy

http://www.wikidata.org/entity/Q34658087

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Modulation of the metabiome by ...... minimal hepatic encephalopathy

@ast

Modulation of the metabiome by ...... minimal hepatic encephalopathy

@en

Modulation of the metabiome by ...... minimal hepatic encephalopathy

@nl

type

label

Modulation of the metabiome by ...... minimal hepatic encephalopathy

@ast

Modulation of the metabiome by ...... minimal hepatic encephalopathy

@en

Modulation of the metabiome by ...... minimal hepatic encephalopathy

@nl

prefLabel

Modulation of the metabiome by ...... minimal hepatic encephalopathy

@ast

Modulation of the metabiome by ...... minimal hepatic encephalopathy

@en

Modulation of the metabiome by ...... minimal hepatic encephalopathy

@nl

P1433

Q34658087-32AAA1F2-5233-4180-9E29-C68EB3973F2B

P1476

Q34658087-FC4B3F99-EB2A-4D24-B1B2-C3F7602B10F9

P2093

Q34658087-315196D6-E13D-43B7-9EB4-D002BB640C0D

Q34658087-37B42818-81C1-40C0-AB85-2406034386BA

Q34658087-423833E6-07EB-4B7D-B334-0AB07F7010B2

Q34658087-4CA823EE-0653-48F8-9818-31DBA5F4006F

Q34658087-50670B02-5F39-4439-839B-E1D60F4D919A

Q34658087-59777E01-163D-44CC-BF33-3FF7E07A42D2

Q34658087-619C764A-616F-4B1A-AA34-3387C9A3CC92

Q34658087-68ACBB9D-1175-4A7A-9305-45CB76C4E7A6

Q34658087-6CB9A7BC-0649-416E-95D1-5F2EF3768C58

Q34658087-8A608837-3AC6-415C-A0FC-6EEBA9F5A0B9

P2860

Q34658087-00E27F2A-8BF4-457C-8C60-0384C6AB9B2F

Q34658087-12549FFC-1018-46FC-ADFF-136624882CC6

Q34658087-15328140-D211-499C-81F4-23801E070657

Q34658087-1707753C-E262-45F7-AAFF-FFB31ACFA323

Q34658087-17348BBA-0DE0-4BD2-9548-50E7E4665A5D

Q34658087-18629F25-FF20-4B51-86C5-236F74EF29E8

Q34658087-3328BC2D-9A27-4E33-BF21-508685A27B25

Q34658087-341A9E7B-EFED-4026-8E3A-9864C95050D7

Q34658087-41C367EE-7A38-4494-9F1D-7E2A8F90E62C

Q34658087-4CCCD271-35F7-4583-B7CE-BEBD355FF2C7

P304

Q34658087-048CCC11-6372-4EB1-96AC-7E175D8A9C76

P31

Q34658087-EBD81853-04B8-4342-AA4A-FDF0DAF199C8

P356

Q34658087-7C5309CB-3243-4DDA-BC99-AFCAFC470792

P407

Q34658087-1D7AFAD3-7729-4F26-98C8-4138B91B750D

P433

Q34658087-C2A88889-04F3-4512-9A4F-83EF49959C24

P478

Q34658087-8D6F6A06-C821-4DC6-B74C-FD4970507766

P577

Q34658087-FEB80E9F-7DEE-4246-AEF1-2BFD3F7889C0

P5875

Q34658087-B5C11588-FC09-4C66-A562-5D6E7E9517AB

P698

Q34658087-18C808CD-281A-4240-BA77-451401755D5A

P921

Q34658087-23D7F5EE-BA38-435F-B553-51114597B9FA

Q34658087-63CCC170-71F4-4170-8B80-A1BB684533FC

Q34658087-73C75E9A-DCE6-4C07-860C-8DDDCEB0AEA1

P932

Q34658087-7AEC09E5-EE47-4CDE-A05C-2A39A996E93E

P356

JOURNAL.PONE.0060042

P1433

P1476

Modulation of the metabiome by ...... minimal hepatic encephalopathy

@en

P2093

Andmorgan Fisher

http://www.w3.org/2001/XMLSchema#string

Arun J Sanyal

http://www.w3.org/2001/XMLSchema#string

Douglas M Heuman

http://www.w3.org/2001/XMLSchema#string

Huzefa Rangwala

http://www.w3.org/2001/XMLSchema#string

Jasmohan S Bajaj

http://www.w3.org/2001/XMLSchema#string

Jason M Ridlon

http://www.w3.org/2001/XMLSchema#string

Kalyani Daita

http://www.w3.org/2001/XMLSchema#string

Masoumeh Sikaroodi

http://www.w3.org/2001/XMLSchema#string

Melanie B White

http://www.w3.org/2001/XMLSchema#string

Michael Fuchs

http://www.w3.org/2001/XMLSchema#string

P2860

Enterotypes of the human gut microbiome

Cytoscape: a software environment for integrated models of biomolecular interaction networks

A core gut microbiome in obese and lean twins

Functional analysis of colonic bacterial metabolism: relevant to health?

An obesity-associated gut microbiome with increased capacity for energy harvest

Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations

Rifaximin treatment in hepatic encephalopathy

Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy.

pcaMethods--a bioconductor package providing PCA methods for incomplete data.

Essential fatty acids and the brain: possible health implications.

P304

e60042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0060042

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236129779

http://www.w3.org/2001/XMLSchema#string

P698

23565181

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

P932

3615021

http://www.w3.org/2001/XMLSchema#string